Federal Trade Commission Statement Concerning Brand Drug Manufacturers' Improper Listing of Patents in the Orange Book
Date
Matter Number
P233900
File
Text of the Policy Statement
(633.47 KB)
Displaying 1 - 11 of 11
Jazz Pharmaceuticals, Inc. v. Avadel CNS Pharmaceuticals, LLC
Date
Citation Number
1:21-cv-00691
Federal Court
District of Delaware
The Federal Trade Commission filed an amicus brief with the U.S. District Court for the District of Delaware in the case of Jazz Pharmaceuticals v. Avadel CNS Pharmaceuticals. The Brief highlights the...
File
FTC to Hold Workshop on Examining Competition Issues Related to Prescription Drug Markets
Date
WHAT: The Federal Trade Commission will host a workshop, “Understanding Competition in Prescription Drug Markets: Entry and Supply Chain Dynamics”. Acting FTC Chairman Maureen K. Ohlhausen and U.S...
FTC Staff Issues FY 2015 Report on Branded Drug Firms’ Patent Settlements with Generic Competitors
Date
The number of reverse-payment patent settlements entered into by pharmaceutical companies in fiscal year 2015 declined from fiscal year 2014, marking a second annual decrease in such settlements...
FTC Announces Agenda for November 8 Workshop on Examining Competition Issues Related to Prescription Drug Markets
Date
The Federal Trade Commission has announced an agenda for its upcoming workshop on competition issues related to prescription drug markets. The workshop, titled “Understanding Competition in...
FTC to Conduct Workshop on November 8, Examining Competition Issues Related to Prescription Drug Markets
Date
The Federal Trade Commission will hold a workshop on November 8, 2017 entitled, “Understanding Competition in Prescription Drug Markets: Entry and Supply Chain Dynamics.” Acting FTC Chairman Maureen K...
Wellbutrin XL Antitrust Litigation, In re
Date
Citation Number
2:08-cv-2431
Federal Court
Eastern District of Pennsylvania
Brief of the Federal Trade Commission as Amicus Curiae before the United States District Court for the Eastern District of Pennsylvania, addressing whether a branded company's commitment not to launch...
File
In re Wellbutrin Antrirust Litigation
(125.48 KB)
Bisaro, Paul
Type of Action
Process Enforcement
Last Updated
FTC Matter/File Number
061 0182
Case Status
Closed
FTC Issues Interim Report on "Authorized Generic" Drugs
Date
The Federal Trade Commission today issued “Authorized Generics: An Interim Report,” which presents the first set of results from a study conducted to examine the short-term and long-term effects of...
Commission Announces Issuance of Information Requests to Generic and Authorized Generic Drug Companies; FTC Approves Proposed Divestiture in Matter of SCI and Alderwoods Group; Commission Approves Proposed Divestiture in Matter of Kyphon, Inc.
Date
Commission issuance of information requests: The Commission has issued information requests to generic and authorized generic drug manufacturers and marketers as part of its ongoing study of the short...
FTC Proposes Study of Competitive Impacts of Authorized Generic Drugs
Date
The Federal Trade Commission today announced its intention to conduct a study of the use, and likely short- and long-term competitive effects, of authorized generics in the prescription drug...
Displaying 1 - 11 of 11